RAD51 and cancer: However, Rad51 is overexpressed in cancer cells relative to normal cells (50, 51) and its selective inhibition by RNA interference increases sensitivity to chemotherapeutic killing of human cancer cells relative to normal cells, both in vitro and in vivo (24).